LUNG CANCER SCREENING

Transcription

1 6TH ANNUAL By making Lung LUNG Cancer CANCER Screening more SCREENING accessible, the malady & CONTINUUM can be diagnosed earlier, OF CARE the best treatment may be prescribed, and a more positive outcome can be expected ACI S 6TH ANNUAL LUNG CANCER SCREENING & CONTINUUM OF CARE Developing, Implementing and Advancing Lung Cancer Screening Programs and Treatments for Competitive Advantage and Improved Outcomes DECEMBER 6-7, 2017 MIAMI, FLORIDA FEATURING A VISIT TO THE CANCER CENTER OF EXCELLENCE - AWARD-WINNING CANCER CARE The Mount Sinai Comprehensive Cancer Center is a nationally recognized, award-winning facility that utilizes a collaborative, multidisciplinary approach to diagnosing and treating cancer. We provide quality care, leading innovation and personalized treatment plans for each patient to treat a broad range of cancers. Our patient-centered focus ensures access to convenient, timely appointments, clinical trials and a host of support services all aimed at helping patients heal. Mount Sinai was the first hospital in Florida to receive the Outstanding Achievement Award from the American College of Surgeons Commission on Cancer (CoC) consecutively for three cycles. The CoC created this award to recognize programs that strive for excellence in providing quality cancer care. In addition, our radiation oncology program was the first in South Florida to earn accreditation from the American College of Radiology. This accreditation represents the highest level of quality and patient safety, and is awarded to facilities meeting specific practice guidelines and technical standards. As a recognized radiation safety provider, Mount Sinai has strict safety measures in place to ensure that patients receive radiation only when it is necessary and in the smallest possible dosage. WHY ATTEND THIS CONFERENCE? Learn how to initiate a comprehensive Lung Cancer Screening program from zero to excellence level Explore how to apply best practices for screening quality control, dosages, and diagnostics To understand the multi- and inter- disciplinary nature of lung cancer prevention, treatment, and post-surgery therapies SPONSORSHIP OPPORTUNITIES MEDIA PARTNERS INCLUDE With leading companies and organizations from the Lung Cancer Screening and Continuum Care industry attending and speaking at our event, we have the perfect opportunity to provide outstanding exposure to a high-level, professional audience. There are varying sponsorship packages available. For further details, please contact Gia Bosch, Manager Sponsorship Sales Milwaukee at x146 or gbosch@acius.net.

2 CONTENT AND THEME CONFIRMED SPEAKERS INCLUDE Lung cancer is the second most commonly diagnosed cancer in both men and women, and the most prevalent cause of cancer death in the United States. A comprehensive array of diagnoses and treatment options, including minimally invasive, robotic-assisted surgery, and access to clinical trials, are important considerations for patients in general. Advances in diagnostic imaging and biomedical research continue to evolve rapidly and it will continue to affect screening and therapeutic procedures and programs. Cost-benefit analysis and public policy implications for coverage and reimbursement will also play a significant role in these. KEY TOPICS Through a series of presentations, sessions, and panel discussions, this event will cover some of the major current concerns of the industry. Initiating a comprehensive Lung Cancer Screening program from zero to excellence level Applying best practices for screening quality control, dosages, and diagnostics Identifying high risk patients Creating guidelines for preventive screening, care, and maintenance Addressing the challenges to implementing screening programs Integrating Lung Cancer Screening and smoking cessation programs Implementing strategies to ensure patient follow-up Deploying Lung Cancer Screening responsibly and equitably Exploring the latest advances in CT imaging and biomedical research Analysing and reporting mechanisms for development of care Understanding the importance of multiand inter- disciplinary nature of lung cancer Balancing regulatory and cost analysis for viability and success Conference Chairperson Andrea Borondy Kitts, MS, MPH, Patient Outreach and Research Specialist LAHEY HOSPITAL AND MEDICAL CENTER Juan Carlos Batlle, MD, MBA, Chief of Thoracic Imaging, Associate Professor, FIU - School of Medicine BAPTIST HEALTH SOUTH FLORIDA Andrew Salner, MD, FACR, Medical Director HARTFORD HEALTHCARE CANCER INSTITUTE AND HARTFORD HOSPITAL Kathryn Taylor, PhD, Professor, Department of Oncology, Cancer Prevention and Control Program LOMBARDI COMPREHENSIVE CANCER CENTER GEORGETOWN UNIVERSITY MEDICAL CENTER Gabriela Dieguez, Principal and Consulting Actuary MILLIMAN Matthew Schabath, PhD, Associate Member, Department of Cancer Epidemiology MOFFITT CANCER CENTER April Plank, DNP, Co-Director THE CENTER FOR LUNG CANCER SCREENING AND PREVENTION at STONY BROOK UNIVERSITY CANCER CENTER Ana Ruiz, Manager, Cancer Program Estelamari Rodriguez, MD, Medical Director Thoracic Oncology, Chair, Women s Centered Care Network Brett Schussel, MSN, FNP-BC, Nurse Practitioner Director of Lung Cancer Screening Program UCLA MEDICAL CENTER Robert C. Gilkeson, MD, Vice Chairman of Research, Department of Radiology UNIVERSITY HOSPITALS - UH CASE MEDICAL CENTER Katherine Y. Tossas-Milligan, PhD, MS, Director, Office of Global Assets and Innovative Approaches (GAIA) to Cancer Equity UNIVERSITY OF ILLINOIS CANCER CENTER Robert A. Winn, MD, Director of the UI Health Cancer Center and Associate Vice Chancellor of Community Based Practice UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM Rafael Meza, PhD, Associate Professor, Department of Epidemiology - School of Public Health, Co-Leader, Cancer Epidemiology and Prevention Program UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER Brendon Stiles, MD, Associate Professor, Department of Cardiothoracic Surgery WEILL CORNELL MEDICAL COLLEGE NEW YORK PRESBYTERIAN HOSPITAL WHO SHOULD ATTEND This two-day conference will offer excellent opportunities for you to network with your peers: CEOs, CIOs, CSOs, Vice-Presidents, Directors, and Senior Managers responsible for Thoracic Cancer/Oncology Centers Cancer/Oncology Centers Hospitals Health Care Systems Physician Clinics Community Health Centers Hospital Management Groups CT scanning companies Key titles include: Medical Doctors Family Practice Physicians Medical Oncologists Internal Medicine Physicians Thoracic, Surgical Oncologists Radiation Oncologists Radiology professionals Physical Therapists Respiratory Therapists Principle Investigators Physician Assistants Nurse Navigators Oncology Nurse Navigators

3 CONFERENCE DAY ONE WEDNESDAY, DECEMBER 6, :00 AM 9:00 AM 9:15 AM 10:00 AM 10:45 AM 11:15 AM 12:00 PM 12:45 PM 1:45 PM 2:30 PM REGISTRATION AND COFFEE CHAIRPERSON S OPENING REMARKS LUNG CANCER SCREENING EXPERIENCE IN AN ESTABLISHED CLINICAL SCREENING PROGRAM Defining a program structure and a system for Reporting on scan results by screening round patient referral and tracking including detection rates, surgical intervention for Using shared decision making and available benign disease and other populations at risk decision aids, including addressing stigma and implicit bias CREATE A RESPONSIBLE LUNG CANCER SCREENING PROGRAM WITHIN AN ACADEMIC MEDICAL CENTER FOR IMMEDIATE FINANCIAL AND EXPERT SUPPORT Identifying and recruiting the necessary Defining the essential aspects of workflow and stakeholders essential for program success infrastructure development Troubleshooting and improving weaker areas of Engaging multi and inter disciplinary players to the program enhance and broaden success chances Brett Schussel, MSN, FNP-BC, Nurse Practitioner Director of Lung Cancer Screening Program UCLA MEDICAL CENTER MORNING REFRESHMENTS NEW DETECTION METHODS FOR LUNG CANCER Enhancing sensitivity and specificity of Improving the care of the patients in a lung cancer abnormalities detected in lung cancer screening screening program Moving from lung cancer risk to a more expanded version of patient care and risk Robert C. Gilkeson, MD, Vice Chairman of Research, Department of Radiology UNIVERSITY HOSPITALS - UH CASE MEDICAL CENTER PRECISION-BASED MEDICINE IN LUNG CANCER SCREENING AND RADIOLOGY READING ROOMS OF THE FUTURE Primary motivation for quantitative imaging in Imaging-based biomarkers in the context of Lung precision medicine Cancer Screening Applying quantitative imaging in everyday radiology practice Matthew Schabath, PhD, Associate Member, Department of Cancer Epidemiology MOFFITT CANCER CENTER LUNCH UPDATE ON LUNG CANCER TREATMENTS AND NEW TECHNOLOGIES Improved diagnostic techniques for treatment of Role of chemotherapy and targeted therapies lung cancer New immunotherapy strategies to treat lung cancer Estelamari Rodriguez, MD, Medical Director Thoracic Oncology, Chair - Women s Centered Care Network COST-BENEFIT ANALYSIS FOR FRAMING PROPOSALS FOR A LUNG CANCER SCREENING FACILITY Gathering data, sources, and methods for Collecting by-stage data on survivorship as a cost-effective screening result of optimized screening efforts Calculating cost-benefit, analyzing equation elements, and seeking improved results overall Gabriela Dieguez, Principal and Consulting Actuary MILLIMAN

4 3:15 PM 3:45 PM 4:30 PM 5:15 PM AFTERNOON REFRESHMENTS CREATING GUIDELINES FOR PREVENTIVE SCREENING, CARE, AND MAINTENANCE Lung Cancer facts and figures Establishing inclusion / exclusion criteria Defining high risk patients and their care path Following up on patient compliance Robert A. Winn, MD, Director of the UI Health Cancer Center and Associate Vice Chancellor of Community Based Practice UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM LUNG CANCER SCREENING: MOVING FORWARD TO IMPLEMENTATION Serving an ethnically and socio-economically Engaging underserved populations in both clinical diverse patient population lung cancer screening protocols and research Recognizing the option of requesting third party programs payment Andrew Salner, MD, FACR, Medical Director HARTFORD HEALTHCARE CANCER INSTITUTE AND HARTFORD HOSPITAL CLOSE OF DAY ONE CONFERENCE DAY TWO THURSDAY, DECEMBER 7, :30 AM 9:00 AM 9:05 AM REGISTRATION AND COFFEE CHAIRPERSON S OPENING REMARKS MAXIMIZE ADHERENCE IN THE LUNG CANCER SCREENING POPULATION Defining adherence in a Lung Cancer Screening Identifying barriers to patient adherence in lung Program cancer screening guidelines Ascertaining strategies to maximize adherence to lung cancer screening guidelines April Plank, DNP, Co-Director THE CENTER FOR LUNG CANCER SCREENING AND PREVENTION AT STONY BROOK UNIVERSITY CANCER CENTER 9:50 AM LUNG CANCER SCREENING: IT IS TIME TO THINK ABOUT QUALITY Expanding the available cancer imaging quality Understanding the importance of imaging quality metrics metrics in reducing false positives rates, and Proposing lung cancer imaging quality metrics to unnecessary procedures monitor lung cancer screening performance Katherine Y. Tossas-Milligan, PhD, MS, Director, Office of Global Assets and Innovative Approaches (GAIA) to Cancer Equity UNIVERSITY OF ILLINOIS CANCER CENTER 10:35 AM 11:05 AM MORNING REFRESHMENTS EVIDENCE-BASED SMOKING CESSATION INTERVENTIONS FOR LUNG CANCER SCREENING PROGRAMS Combining Lung Cancer Screening and Cessation Overview of Smoking Cessation Interventions in Interventions for the potential to increase the NCI s SCALE collaboration abstinence in a large number of hard-to-reach, Summary of a telephone-based Cessation long-term smokers at high risk for multiple Intervention in the lung screening setting tobacco-related diseases Kathryn Taylor, PhD, Professor, Department of Oncology, Cancer Prevention and Control Program LOMBARDI COMPREHENSIVE CANCER CENTER GEORGETOWN UNIVERSITY MEDICAL CENTER

5 11:50 PM 12:35 PM 1:35 PM 2:20 PM 3:05 PM 3:15 PM 3:45 PM 4:30 PM 5:30 PM MODELING SMOKING TRENDS AND LUNG CANCER SCREENING TO 2060 IN THE US Changing screening eligibility Joint impact of screening and cessation programs Enhancing the impact of screening programs on smoking, lung cancer and life expectancy Rafael Meza, PhD, Associate Professor, Co-Leader, Department of Epidemiology - School of Public Health, Co-Leader, Cancer Epidemiology and Prevention Program UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER LUNCH MANAGEMENT OF SCREEN DETECTED LUNG NODULES Updating on Lung-RADS classification Optimizing work up and diagnosis of screen Surgical management of screen detected cancers detected nodules Brendon Stiles, MD, Associate Professor, Department of Cardiothoracic Surgery WEILL CORNELL MEDICAL COLLEGE NEW YORK PRESBYTERIAN HOSPITAL DEVELOPING AND IMPLEMENTING A SUCCESSFUL LUNG SCREENING PROGRAM Creating a center of excellence around lung Developing a team approach, collecting the right screening data, and closing the loop Data from the Baptist Health Experience, 2014-present Juan Carlos Batlle, MD, MBA, Chief of Thoracic Imaging, Associate Professor, FIU - School of Medicine BAPTIST HEALTH SOUTH FLORIDA CHAIRPERSON S CLOSING REMARKS END OF CONFERENCE AND AFTERNOON REFRESHMENTS TRANSPORTATION TO EXPERIENCE THE MOUNT SINAI MEDICAL CENTER TEAM APPROACH Lung cancer treatment is a highly complex field that requires the expertise of various specialized physicians. Mount Sinai s thoracic oncology team meets regularly to apply its collective knowledge and extensive experience to meet each patient s needs. Participants in these multidisciplinary tumor conferences include thoracic surgeons, pulmonologists, radiologists, pathologists, radiation and medical oncologists. Together, these specialists analyze and discuss molecular analysis of tumors, chemo-sensitivity testing and other complex medical factors to identify the most effective treatment plan for each patient. In addition to these medical specialties, a host of other supportive services are involved to ensure complete patient care and well-being. Ana Ruiz, Manager, Cancer Program TRANSPORTATION TO VENUE

6 CONFERENCE SPEAKERS Andrea Borondy Kitts is a retired engineering executive with 32 years of experience in Aerospace. She lost her husband to lung cancer in April 2013 and is now a lung cancer and patient advocate and consultant. She works part time as a patient outreach and research specialist at Lahey Hospital and Medical Center in the lung cancer screening program where she assists with research and helps provide a patient perspective to the program. Andrea is also an Associate Editor for the Journal of the American College of Radiology (JACR) and a member of the American College of Radiology Patient and Family Centered Care Commission. She is the COO of Prosumer Health, a start-up company that is developing a smartphone accessible, AI-driven, evidenced-based health maintenance and improvement platform for consumers. She also volunteers for the American Lung Association, for Free to Breathe and for Hartford Hospital. Andrea has a BS in Mechanical Engineering from UVM, a MS in Management from MIT and a Master s in Public Health degree from the University of Connecticut. Juan Carlos Batlle, MD, MBA, Chief of Thoracic Imaging, Associate Professor, FIU - School of Medicine BAPTIST HEALTH SOUTH FLORIDA Juan Carlos Batlle, MD, MBA, is a partner at Radiology Associates of South Florida. He serves as the Chief of Thoracic Imaging for Baptist Health, the Director of the CT Lung Screening Program for the Miami Cancer Institute, and Director of the Advanced Cardiac Imaging Fellowship at Miami Cardiac and Vascular Institute. The Baptist CT Lung Screening program screens over 1500 patients every year, and covers a geographic area from Coral Springs in North Broward down to the Florida Keys. Gabriela Dieguez, Principal and Consulting Actuary MILLIMAN Gabriela has provided actuarial and consulting services to a wide range of clients, including commercial insurers, Medicare Advantage organizations, pharmaceutical companies, Blue Cross/Blue Shield plans, HMOs, and healthcare providers. She has extensive experience in pricing and valuation, analyzing benefit utilization, forecasting trends, and performing claims analytics for particular disease states. Gabriela has advised pharmaceutical companies and other clients on actuarial topics related to health care reform, Medicare Advantage and Part D, risk sharing contracting, and payer economic issues. In addition, her consulting with both plan sponsors and providers has included Medicare bid certifications, rate development and benefit design, medical claim liabilities evaluation, actuarial support for mergers and acquisitions, and financial feasibility analysis. Prior to joining Milliman, Gabriela worked for a consulting firm where she was involved in rate and reserve calculations, financial projections, profitability analysis, reinsurance contracts analysis, product development, and rate adequacy. Robert C. Gilkeson, MD, Vice Chairman of Research, Department of Radiology UNIVERSITY HOSPITALS - UH CASE MEDICAL CENTER Robert Gilkeson, M.D. is the director of Cardiothoracic Imaging at University Hospitals/Cleveland Medical Center. He serves as Vice Chairman of Research in the Department of Radiology, and a Professor in Radiology at Case Western Reserve Medical School. He completed his medical school training at Case Western Reserve School of Medicine, and residency and fellowship at Duke University Medical Center. Dr. Gilkeson also serves as the director of the lung cancer screening program at the University Hospitals Seidman Cancer Center. Dr Gilkeson has published and presented extensively on new methods of improved detection and characterization of lung nodules and lung cancer. He has been the Principal and Co-investigator of several industry and federally funded research grants involved in the improved diagnostic performance of low dose lung cancer screening with CT. Rafael Meza, PhD, Associate Professor, Co-Leader, Department of Epidemiology - School of Public Health, Co-Leader, Cancer Epidemiology and Prevention Program UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER Dr. Meza is associate professor in the Department of Epidemiology at the University of Michigan School of Public Health and co-leader of the Cancer Epidemiology and Prevention Program at the University of Michigan Comprehensive Cancer Center. Dr. Meza s research interests lie at the interface of epidemiology, biostatistics and biomathematics. In particular, he is interested in cancer risk assessment and the analysis of cancer epidemiology data using mechanistic models of carcinogenesis. He is also interested in the mathematical modeling of chronic and infectious disease dynamics and its applications in disease prevention public health policy design. Dr. Meza is Coordinating Principal Investigator of the Cancer Intervention and Surveillance Modeling Network (CISNET) lung group. He is also Honorary Professor at the Mexico National Institute of Public Health (INSP), and a member of Mexico s National System of Investigators (SNI II). Currently, Dr. Meza is developing models to evaluate the impact of screening and smoking cessation on lung cancer risk. Additional projects include the development of methodologies to investigate the effects of infectious disease dynamics on the risk of cancers with infectious disease etiology, particularly HPV-related cancers, assessing the acceptability of HPV screening in minority populations in Latin America, and modeling the impact of policies on tobacco use. April Plank, DNP, Co-Director THE CENTER FOR LUNG CANCER SCREENING AND PREVENTION AT STONY BROOK UNIVERSITY CANCER CENTER April Plank is the Co-Director of The Center for Lung Cancer Screening and Prevention at Stony Brook University Cancer Center. She has an active clinical practice coupled with various research endeavors. Her 25 year career as a nurse practitioner has been spent focused on pulmonary diseases with a sub-specialty in lung cancer since She opened the center s lung cancer screening program in 2013 with over 900 patients screened to date. She is the principle investigator in a number of research studies involving patients being screened for and diagnosed with lung cancer. Throughout her career, Dr. Plank has created various programs to address patient distress with the most recent being distress during cancer screening and diagnosis. She has launched a number of support groups including Stony Brook s lung cancer support group, which is the longest running support group in the country and for which she received the prestigious Lung Cancer Alliance Support Group Facilitator of the year award in She is excited to share details of the program at Stony Brook with the participants of this program.

7 Estelamari Rodriguez, MD, Medical Director Thoracic Oncology, Chair - Women s Centered Care Network Dr. Estelamari Rodriguez is a board-certified medical oncologist specializing in lung cancer treatment at Mount Sinai Comprehensive Cancer Center. She also chairs the Women s Centered Care Program at Mount Sinai Medical Center. Dr. Rodriguez received her medical degree from State University of New York (SUNY) Downstate College of Medicine. She completed her internal medicine residency at the Columbia University Presbyterian Medical Center and her medical oncology fellowship at the University of Pennsylvania. Dr. Rodriguez also has a master s degree in Public Health from the Universidad Autonoma de Madrid, Spain. Andrew Salner, MD, FACR, Medical Director HARTFORD HEALTHCARE CANCER INSTITUTE AND HARTFORD HOSPITAL Andrew L. Salner, M.D.FACR is currently Medical Director of the Hartford HealthCare Cancer Institute at Hartford Hospital, where he also serves as a practicing radiation oncologist. Dr. Salner received his Bachelor s Degree and M.D. Degree from Brown University. He served a Residency in Internal Medicine at Hartford Hospital, a Fellowship in Radiation Therapy at the Joint Center for Radiation Therapy at the Harvard Medical School. In 1982 he was named the Medical Director of Radiation Oncology at Hartford Hospital, a position he held for 34 years. In 2007, Hartford Hospital s Gray Cancer Center was named as one of 16 National Cancer Institute (NCI) Community Cancer Center Programs (NCCCP). Dr. Salner served as Principal Investigator for this program. His research interests include lung cancer screening, cancer genomics, cancer disparities, and cancer survivorship. Dr. Salner serves on numerous hospital, regional, and national committees. He was founding Chair and now past Chair and Board member of the Connecticut Cancer Partnership, Connecticut s CDC recognized comprehensive cancer coalition. He has served on and chaired numerous American Cancer Society and ASTRO (American Society for Radiation Oncology) committees and boards. He makes frequent national presentations in his research areas, and has authored numerous articles and book chapters. Matthew Schabath, PhD, Associate Member, Department of Cancer Epidemiology MOFFITT CANCER CENTER Dr. Matthew Schabath is an Associate Member in the Department of Cancer Epidemiology at the Moffitt Cancer Center, Tampa, Florida. He received his Ph.D in Epidemiology from the University of Texas in 2003 and has over 80 peer-reviewed publications of studying tobacco-related diseases including lung cancer, bladder cancer, COPD, and heart disease. Dr. Schabath s earliest work focused on etiology and susceptibility of cancer with a particular focus on the interplay of inherited genetics and exposures on lung cancer risk. Since joining the Moffitt Cancer Center in 2008, Dr. Schabath s research portfolio expanded to include the study of genomics on treatment response and patient outcomes, precision-medicine using quantitative imaging/radiomics, the natural history of cancer-causing infectious diseases, and health disparities research. With respect to lung cancer screening, Dr. Schabath is the PI of Moffitt s lung cancer screening research program and is developing quantitative image biomarkers for risk assessment, diagnostic discrimination, and to reduce overdiagnosis. Brett Schussel, MSN, FNP-BC, Nurse Practitioner Director of Lung Cancer Screening Program UCLA MEDICAL CENTER Brett Schussel has taken on varying roles as a nurse practitioner at UCLA Medical Center since receiving his Masters of Science degree from UCLA in After spending several years in Thoracic Surgery, Brett was chosen by the Department of Radiology to create a comprehensive lung cancer screening program for the hospital system. He is passionate about lung cancer screening and the importance of creating a multidisciplinary approach to both screening and treatment. He is involved in lung cancer research and is continually altering and updating the current screening program to improve outcomes for patients, as well as reimbursement opportunities for the hospital system. He resides in Agoura Hills, CA with his wife, 10-month-old son, and two dogs. Brendon Stiles, MD, Associate Professor, Department of Cardiothoracic Surgery WEILL CORNELL MEDICAL COLLEGE NEW YORK PRESBYTERIAN HOSPITAL Dr. Stiles is an Associate Professor of Cardiothoracic Surgery at New York-Presbyterian Hospital, Weill Cornell Medicine. Dr. Stiles undertook general surgery training at the University of Virginia and cardiothoracic surgical training at New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. He is a member of the IASLC, the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, and the American College of Surgeons. Dr. Stiles expertise is in the minimally invasive surgical management of lung and esophageal cancer. He has written numerous clinical manuscripts and book chapters on lung cancer screening, staging and management of lung nodules and of early lung cancer, and perioperative care of lung cancer patients. Additionally, he has written extensively on outcomes in esophageal cancer, particularly as it relates to neoadjuvant therapy and surgical strategies. Dr. Stiles is also a funded basic science researcher with a focus on lung cancer. Dr. Stiles is the Vice President of the New York General Thoracic Surgical Club. He is on the Board of Directors and is Vice Chair of the Scientific Advisory Committee of the Lung Cancer Research Foundation, a national foundation supporting lung cancer research. He is also a scientific reviewer and panel chair for the Department of Defense CDMRP Lung Cancer Program and a scientific reviewer for the Thoracic Surgery Foundation for Research and Education. Dr. Stiles is an active lung cancer advocate on Twitter (@BrendonStilesMD). Kathryn Taylor, PhD, Professor, Department of Oncology, Cancer Prevention and Control Program LOMBARDI COMPREHENSIVE CANCER CENTER GEORGETOWN UNIVERSITY MEDICAL CENTER Dr. Taylor is a tenured Professor in the Department of Oncology and a member of the Lombardi Comprehensive Cancer Center s Cancer Prevention and Control Program. Dr. Taylor s research focuses on the clinical and public health translation of lung cancer screening as a teachable moment for smoking cessation and relapse prevention. In collaboration with several lung cancer screening programs, Dr. Taylor is conducting an NCI-funded telephone-based cessation intervention trial among smokers who are undergoing lung cancer screening. This research addresses a central issue in tobacco control, regarding the development of methods to access and assist long-term smokers who are not actively seeking assistance with smoking cessation. Lung cancer screening programs are beginning to screen large numbers of current smokers, which means that even a small improvement in smoking cessation following screening will have an important public health impact.

8 Katherine Y. Tossas-Milligan, PhD, MS, Director, Office of Global Assets and Innovative Approaches (GAIA) to Cancer Equity UNIVERSITY OF ILLINOIS CANCER CENTER Dr. Kathy Tossas-Milligan is a trained cancer epidemiologist, and healthcare executive with 17 years of cumulative experience in molecular diagnostics product development, non-profit management, healthcare quality and cancer equity outcomes research. She currently serves as the Director of Global Assets and Innovative Approaches (GAIA) for Health Equity at the University of Illinois Cancer Center, where she oversees the development of assets-based global partnerships focused on identifying innovative cancer research ideas, and best care practices proven successful in under-resourced, and underserved areas across the globe, to apply such practices towards improving the health of underserved populations locally. Developing global to local partnerships include Cuba, Hungary, Uganda, Ethiopia, and various countries in South America. Prior to joining UICC, Dr. Tossas-Milligan worked at the American Hospital Association, overseeing outcomes, practice and process data across five national quality improvement initiatives. She also held leadership positions at the Metropolitan Chicago Breast Cancer Quality Consortium and the American Cancer Society. Robert A. Winn, MD, Director of the UI Health Center and Associate Vice Chancelor of Community Based Practice UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM An accomplished physician-scientist and proponent of the bench to community model, Dr. Winn works tirelessly to bridge the gap between basic science and community-based health care. His basic science research, which has been supported by multiple NIH and VA Merit awards, focuses on the translational aspects of the role the Wnt pathway plays in lung cancer. He has received national and international acclaim for his efforts to empower underserved patient populations, improve health care delivery, and ensure equal access to cutting-edge medical treatments. He is a principal investigator on several community-based NIH- and NCI-funded projects, including the All of Us Precision Medicine Initiative. Dr. Winn, a pulmonary and critical care specialist, received his medical degree from the University of Michigan Medical School in Ann Arbor. He completed his medical residency at Rush Presbyterian St. Luke s Medical Center in Chicago, and a Pulmonary/Critical Care Medicine fellowship at the University of Colorado School of Medicine. He is a member of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine. VENUE INFORMATION Solé on the Ocean Collins Ave Sunny Isles Beach, FL Centrally located within the popular communities of Golden Beach, Bal Harbour, and Aventura, and only minutes from the culture and night life of South Beach and the Art Deco District, Solé is conveniently located a short distance from the South Beach dance clubs, pulsing with Latin rhythms and world-renowned shopping. Overlooking the shimmering sands and turquoise Atlantic waters, Solé on the Ocean is located just north of Miami Beach, midway between Miami and Fort Lauderdale on picturesque Sunny Isles Beach. Amenities include our award-winning restaurant Fresh American Bistro, an ocean-side pool, a private beach club, fitness room, sauna & steam rooms. The resort features 249 contemporary guest rooms and suites each with a private terrace and floor to ceiling windows. Guests can choose from a variety of rooms overlooking city lights or sweeping ocean views. Add 6,500 square feet of exquisitely appointed, naturally-lit banquet and meeting rooms and Solé is lavish without the attitude. ACTIVE COMMUNICATIONS INTERNATIONAL Active Communications International, Inc. (ACI) is a leader in conference planning and production. With offices in Chicago, London, Pune, Portland, Poznan and Milwaukee, we produce world-class events focusing on areas of most relevance to our served industry sectors. We are dedicated to deliver high-quality, informative and value added strategic business conferences where audience members, speakers, and sponsors can transform their business, develop key industry contacts and walk away with new resources. Mission Statement: ACI s mission is to unite key industry influencers and leaders to build strong relationships and enable our clients to achieve operational efficiencies, maintain competitive advantage in the marketplace, and increase their profitability. Quality: ACI invites senior-level executives and key industry leaders to share their insights and real-life working experiences with our audience. Our unique conference format offers an intimate and time-efficient educational development platform where our attendees can meet one-on-one with the people that can assist them in achieving their goals. Research: ACI offers cutting-edge conferences that are developed through extensive research and development with industry experts to bring you the latest trends, forecasts, and best practices. Experience: Our team of experienced conference producers and managers know you and your business demands. ACI has the resources, knowledge, and experience to create the events you need to remain on the forefront of your industry. Sofia Zutautas, Senior Conference Producer, thanks contributing professionals for their insights, recommendations, and participation.